A detailed history of Trust Point Inc. transactions in Incyte Corp stock. As of the latest transaction made, Trust Point Inc. holds 3,126 shares of INCY stock, worth $216,412. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,126
Previous 3,888 19.6%
Holding current value
$216,412
Previous $236 Million 12.33%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$57.33 - $68.61 $43,685 - $52,280
-762 Reduced 19.6%
3,126 $207 Million
Q2 2024

Jul 24, 2024

SELL
$51.18 - $63.75 $23,849 - $29,707
-466 Reduced 10.7%
3,888 $236 Million
Q1 2024

Apr 19, 2024

SELL
$56.55 - $66.59 $394,605 - $464,665
-6,978 Reduced 61.58%
4,354 $248 Million
Q4 2023

Jan 23, 2024

BUY
$52.16 - $64.19 $591,077 - $727,401
11,332 New
11,332 $712 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.